Aldeyra Therapeutics, Inc. (ALDX) is a publicly traded Healthcare sector company. As of November 13, 2026, ALDX trades at $0.68 with a market cap of $38.03M and a P/E ratio of -2.13. ALDX moved +3.24% today. Year to date, ALDX is -84.69%; over the trailing twelve months it is -87.07%. Its 52-week range spans $0.53 to $6.81. Analyst consensus is neutral with an average price target of $2.00. Rallies surfaces ALDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ALDX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.68 |
| Market Cap | $38.03M |
| P/E Ratio | -2.13 |
| EPS | $-0.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.81 |
| 52-Week Low | $0.53 |
| Volume | 694.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-33.85M |
| Gross Margin | 0.00% |
1 analysts cover ALDX: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.00.